{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:12:15Z","timestamp":1790655135468,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K06811"],"award-info":[{"award-number":["JP21K06811"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K06878"],"award-info":[{"award-number":["JP21K06878"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Foundation for Pharmaceutical Sciences"},{"name":"he Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78321-6","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T01:03:35Z","timestamp":1730423015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of esaxerenone on the onset of aortic endothelial dysfunction and circulating microparticles in type 1 diabetic male mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Kumiko","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"78321_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1753-0407.12521","volume":"9","author":"Y Shi","year":"2017","unstructured":"Shi, Y. & Vanhoutte, P. M. Macro- and microvascular endothelial dysfunction in diabetes. J. Diabetes  9, 434\u2013449. https:\/\/doi.org\/10.1111\/1753-0407.12521 (2017).","journal-title":"J. Diabetes"},{"key":"78321_CR2","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00424-016-1839-0","volume":"468","author":"M Siragusa","year":"2016","unstructured":"Siragusa, M. & Fleming, I. The eNOS signalosome and its link to endothelial dysfunction. Pflugers Arch. 468, 1125\u20131137. https:\/\/doi.org\/10.1007\/s00424-016-1839-0 (2016).","journal-title":"Pflugers Arch."},{"key":"78321_CR3","doi-asserted-by":"publisher","unstructured":"Bender, S. B., McGraw, A. P., Jaffe, I. Z. & Sowers, J. R. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 62, 313\u2013319. https:\/\/doi.org\/10.2337\/db12-0905 (2013).","DOI":"10.2337\/db12-0905"},{"key":"78321_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1758-5996-6-90","volume":"6","author":"T da Bruder-Nascimento","year":"2014","unstructured":"da Bruder-Nascimento, T., Silva, M. A. & Tostes, R. C. The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes. Diabetol. Metab. Syndr. 6, 90. https:\/\/doi.org\/10.1186\/1758-5996-6-90 (2014).","journal-title":"Diabetol. Metab. Syndr."},{"key":"78321_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.phrs.2018.06.002","volume":"134","author":"SM Brown","year":"2018","unstructured":"Brown, S. M., Meuth, A. I., Davis, J. W., Rector, R. S. & Bender, S. B. Mineralocorticoid receptor antagonism reverses diabetes-related coronary vasodilator dysfunction: a unique vascular transcriptomic signature. Pharmacol. Res. 134, 100\u2013108. https:\/\/doi.org\/10.1016\/j.phrs.2018.06.002 (2018).","journal-title":"Pharmacol. Res."},{"key":"78321_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphys.2015.00269","volume":"6","author":"MA Silva","year":"2015","unstructured":"Silva, M. A. et al. Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO\/GC signaling. Front. Physiol. 6, 269. https:\/\/doi.org\/10.3389\/fphys.2015.00269 (2015).","journal-title":"Front. Physiol."},{"key":"78321_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cardfail.2006.01.002","volume":"12","author":"HM Thai","year":"2006","unstructured":"Thai, H. M., Do, B. Q., Tran, T. D., Gaballa, M. A. & Goldman, S. Aldosterone antagonism improves endothelial dependent-vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production. J. Card. Fail. 12, 240\u2013245. https:\/\/doi.org\/10.1016\/j.cardfail.2006.01.002 (2006).","journal-title":"J. Card Fail."},{"key":"78321_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2015.06.015","volume":"761","author":"K Arai","year":"2015","unstructured":"Arai, K. et al. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. Eur. J. Pharmacol. 761, 226\u2013234. https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.015 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"78321_CR9","doi-asserted-by":"publisher","first-page":"H1004","DOI":"10.1152\/ajpheart.00842.2004","volume":"288","author":"MC Mart\u00ednez","year":"2005","unstructured":"Mart\u00ednez, M. C., Tesse, A., Zobairi, F. & Andriantsitohaina, R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am. J. Physiol. Heart Circ. Physiol. 288, H1004\u2013H1009. https:\/\/doi.org\/10.1152\/ajpheart.00842.2004 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"78321_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"Pol","year":"2012","unstructured":"Pol, Boeing, E., Harrison, A. N., Sturk, P., Nieuwland, R. & Van,, ,, A. & Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64, 676\u2013705. https:\/\/doi.org\/10.1124\/pr.112.005983 (2012).","journal-title":"Pharmacol. Rev."},{"key":"78321_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000438782","volume":"132","author":"WQ Han","year":"2015","unstructured":"Han, W. Q., Chang, F. J., Wang, Q. R. & Pan, J. Q. Microparticles from patients with the acute coronary syndrome impair vasodilatation by inhibiting the Akt\/eNOS-Hsp90 signaling pathway. Cardiology  132, 252\u2013260. https:\/\/doi.org\/10.1159\/000438782 (2015).","journal-title":"Cardiology"},{"key":"78321_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fcvm.2017.00074","volume":"4","author":"MTK Zaldivia","year":"2017","unstructured":"Zaldivia, M. T. K., McFadyen, J. D., Lim, B., Wang, X. & Peter, K. Platelet-derived microvesicles in cardiovascular diseases. Front. Cardiovasc. Med. 4, 74. https:\/\/doi.org\/10.3389\/fcvm.2017.00074 (2017).","journal-title":"Front. Cardiovasc. Med."},{"key":"78321_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/apha.12561","volume":"216","author":"K Ishida","year":"2016","unstructured":"Ishida, K. et al. Circulating microparticles from diabetic rats impair endothelial function and regulate endothelial protein expression. Acta Physiol. (Oxford)  216, 211\u2013220. https:\/\/doi.org\/10.1111\/apha.12561 (2016).","journal-title":"Acta Physiol. (Oxf)"},{"key":"78321_CR14","doi-asserted-by":"publisher","first-page":"174630","DOI":"10.1016\/j.ejphar.2021.174630","volume":"913","author":"K Taguchi","year":"2021","unstructured":"Taguchi, K., Kaneko, N., Okudaira, K., Matsumoto, T. & Kobayashi, T. Endothelial dysfunction caused by circulating microparticles from diabetic mice is reduced by PD98059 through ERK and ICAM-1. Eur. J. Pharmacol. 913, 174630. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174630 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"78321_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1530\/JOE-18-0616","volume":"241","author":"K Taguchi","year":"2019","unstructured":"Taguchi, K., Narimatsu, H., Matsumoto, T. & Kobayashi T.\u3000ERK-containing microparticles from a diabetic mouse induce endothelial dysfunction. J. Endocrinol. 241, 221\u2013233. https:\/\/doi.org\/10.1530\/JOE-18-0616 (2019).","journal-title":"J. Endocrinol."},{"key":"78321_CR16","doi-asserted-by":"publisher","first-page":"e39235","DOI":"10.1371\/journal.pone.0039235","volume":"7","author":"N L\u00f3pez, Andr\u00e9s","year":"2012","unstructured":"L\u00f3pez, Andr\u00e9s, N. et al. Increased microparticle production and impaired microvascular endothelial function in aldosterone-salt-treated rats: protective effects of polyphenols. PLoS ONE  7, e39235. https:\/\/doi.org\/10.1371\/journal.pone.0039235 (2012).","journal-title":"PLOS ONE"},{"key":"78321_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2121-14-23","volume":"14","author":"NS Barteneva","year":"2013","unstructured":"Barteneva, N. S. et al. Circulating microparticles: square the circle. BMC Cell. Biol. 14, 23. https:\/\/doi.org\/10.1186\/1471-2121-14-23 (2013).","journal-title":"BMC Cell. Biol."},{"key":"78321_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","volume":"31","author":"O Morel","year":"2011","unstructured":"Morel, O., Jesel, L., Freyssinet, J. M., Freyssinet, J. M. & Toti, F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler. Thromb. Vasc. Biol. 31, 15\u201326. https:\/\/doi.org\/10.1161\/ATVBAHA.109.200956 (2011).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"78321_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/157339909789804404","volume":"5","author":"S Nomura","year":"2009","unstructured":"Nomura, S. Dynamic role of microparticles in type 2 diabetes mellitus. Curr. Diabetes Rev. 5, 245\u2013251. https:\/\/doi.org\/10.2174\/157339909789804404 (2009).","journal-title":"Curr. Diabetes Rev."},{"key":"78321_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1475-2840-13-88","volume":"13","author":"B Chen","year":"2014","unstructured":"Chen, B. et al. Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes. Cardiovasc. Diabetol. 13, 88. https:\/\/doi.org\/10.1186\/1475-2840-13-88 (2014).","journal-title":"Cardiovasc. Diabetol."},{"key":"78321_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-018-0042-6","volume":"40","author":"M Knapp","year":"2019","unstructured":"Knapp, M., Tu, X. & Wu, R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol. Sin.  40, 1\u20138. https:\/\/doi.org\/10.1038\/s41401-018-0042-6 (2019).","journal-title":"Acta Pharmacol. Sin"},{"key":"78321_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.physbeh.2017.01.018","volume":"178","author":"RL Erickson","year":"2017","unstructured":"Erickson, R. L., Browne, C. A. & Lucki, I. Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus. Physiol. Behav. 178, 166\u2013171. https:\/\/doi.org\/10.1016\/j.physbeh.2017.01.018 (2017).","journal-title":"Physiol. Behav."},{"key":"78321_CR23","doi-asserted-by":"publisher","unstructured":"Mayyas, F., Alzoubi, K. H. & Ruwidah Bonyan, R. The role of spironolactone on myocardial oxidative stress in rat model of streptozotocin-induced diabetes. Cardiovasc. Ther. 35 https:\/\/doi.org\/10.1111\/1755-5922.12242 (2017).","DOI":"10.1111\/1755-5922.12242"},{"key":"78321_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt, B. et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 348, 1309\u20131321. https:\/\/doi.org\/10.1056\/NEJMoa030207 (2003).","journal-title":"N Engl. J. Med."},{"key":"78321_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad, F. et al. Eplerenone in patients with systolic heart failure and mild symptoms. N. Engl. J. Med. 364, 11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1009492 (2011).","journal-title":"N Engl. J. Med."},{"key":"78321_CR26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","volume":"350","author":"A McCurley","year":"2012","unstructured":"McCurley, A. & Jaffe, I. Z. Mineralocorticoid receptors in vascular function and disease. Mol. Cell. Endocrinol. 350, 256\u2013265. https:\/\/doi.org\/10.1016\/j.mce.2011.06.014 (2012).","journal-title":"Mol. Cell. Endocrinol."},{"key":"78321_CR27","doi-asserted-by":"publisher","first-page":"e88942","DOI":"10.1172\/jci.insight.88942","volume":"1","author":"JJ DuPont","year":"2016","unstructured":"DuPont, J. J. et al. Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging. JCI Insight  1, e88942. https:\/\/doi.org\/10.1172\/jci.insight.88942 (2016).","journal-title":"JCI Insight"},{"key":"78321_CR28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/nm.2891","volume":"18","author":"A McCurley","year":"2012","unstructured":"McCurley, A. et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med. 18, 1429\u20131433. https:\/\/doi.org\/10.1038\/nm.2891 (2012).","journal-title":"Nat. Med."},{"key":"78321_CR29","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/ATVBAHA.111.229070","volume":"31","author":"BG Newfell","year":"2011","unstructured":"Newfell, B. G. et al. Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways. Arterioscler. Thromb. Vasc. Biol. 31, 1871\u20131880. https:\/\/doi.org\/10.1161\/ATVBAHA.111.229070 (2011).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"78321_CR30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2011.05.029","volume":"341","author":"N Sekizawa","year":"2011","unstructured":"Sekizawa, N. et al. Transcriptome analysis of aldosterone-regulated genes in human vascular endothelial cell lines stably expressing mineralocorticoid receptor. Mol. Cell. Endocrinol. 341, 78\u201388. https:\/\/doi.org\/10.1016\/j.mce.2011.05.029 (2011).","journal-title":"Mol. Cell. Endocrinol."},{"key":"78321_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.trsl.2017.01.001","volume":"183","author":"JD Tune","year":"2017","unstructured":"Tune, J. D., Goodwill, A. G., Sassoon, D. J. & Mather, K. J. Cardiovascular consequences of metabolic syndrome. Trans. Res. 183, 57\u201370. https:\/\/doi.org\/10.1016\/j.trsl.2017.01.001 (2017).","journal-title":"Trans. Res."},{"key":"78321_CR32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2337\/db14-0670","volume":"64","author":"R Garg","year":"2015","unstructured":"Garg, R. et al. Mineralocorticoid receptor blockade improves coronary microvascular function in individuals with type 2 diabetes. Diabetes  64, 236\u2013242. https:\/\/doi.org\/10.2337\/db14-0670 (2015).","journal-title":"Diabetes"},{"key":"78321_CR33","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1210\/jc.2007-0393","volume":"92","author":"HV Joffe","year":"2007","unstructured":"Joffe, H. V. et al. Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitus. J. Clin. Endocrinol. Metab. 92, 2552\u20132558. https:\/\/doi.org\/10.1210\/jc.2007-0393 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"78321_CR34","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","volume":"34","author":"N Sch\u00e4fer","year":"2013","unstructured":"Sch\u00e4fer, N. et al. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. Eur. Heart J. 34, 3515\u20133524. https:\/\/doi.org\/10.1093\/eurheartj\/eht095 (2013).","journal-title":"Eur. Heart J."},{"key":"78321_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s0014-2999(00)00764-0","volume":"408","author":"A Erol","year":"2000","unstructured":"Erol, A. & Ko\u015fay, S. Effects of aminoguanidine administration on vascular hyporeactivity in thoracic aorta from endotoxaemic rats. Eur. J. Pharmacol. 408, 175\u2013181. https:\/\/doi.org\/10.1016\/s0014-2999(00)00764-0 (2000).","journal-title":"Eur. J. Pharmacol."},{"key":"78321_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1161\/01.CIR.0000124065.31211.6E","volume":"109","author":"S Martin","year":"2004","unstructured":"Martin, S. et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation  109, 1653\u20131659. https:\/\/doi.org\/10.1161\/01.CIR.0000124065.31211.6E (2004).","journal-title":"Circulation"},{"key":"78321_CR37","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1111\/j.1538-7836.2010.04007.x","volume":"8","author":"E Shantsila","year":"2010","unstructured":"Shantsila, E., Kamphuisen, P. W. & Lip, G. Y. H. Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J. Thromb. Haemost.  8, 2358\u20132368. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04007.x (2010).","journal-title":"J. Thromb. Haemost"},{"key":"78321_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.vph.2006.08.002","volume":"45","author":"G Yetik-Anacak","year":"2006","unstructured":"Yetik-Anacak, G. & Catravas, J. D. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vasc. Pharmacol. 45, 268\u2013276. https:\/\/doi.org\/10.1016\/j.vph.2006.08.002 (2006).","journal-title":"Vascul Pharmacol."},{"key":"78321_CR39","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1016\/s0024-3205(99)00113-7","volume":"64","author":"H Liu","year":"1999","unstructured":"Liu, H., Song, D. & Lee, S. S. Increased nitric oxide synthase expression in aorta of cirrhotic rats. Life Sci. 64, 1753\u20131759. https:\/\/doi.org\/10.1016\/s0024-3205(99)00113-7 (1999).","journal-title":"Life Sci."},{"key":"78321_CR40","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","volume":"108","author":"TM Bui","year":"2020","unstructured":"Bui, T. M., Wiesolek, H. L. & Sumagin, R. Icam-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis. J. Leukoc. Biol. 108, 787\u2013799. https:\/\/doi.org\/10.1002\/JLB.2MR0220-549R (2020).","journal-title":"J. Leukoc. Biol."},{"key":"78321_CR41","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1089\/ARS.2008.2204","volume":"11","author":"A Rahman","year":"2009","unstructured":"Rahman, A. & Fazal, F. Hug tightly and say goodbye: role of endothelial icam-1 in leukocyte transmigration. Antioxid. Redox Signal. 11, 823\u2013839. https:\/\/doi.org\/10.1089\/ARS.2008.2204 (2009).","journal-title":"Antioxid. Redox Signal."},{"key":"78321_CR42","doi-asserted-by":"publisher","first-page":"H2786","DOI":"10.1152\/ajpheart.00720.2007","volume":"293","author":"R Sumagin","year":"2007","unstructured":"Sumagin, R. & Sarelius, I. H. A role for icam-1 in maintenance of leukocyte-endothelial cell rolling interactions in inflamed arterioles. Am. J. Physiol. Heart Circ. Physiol. 293, H2786\u2013H2798. https:\/\/doi.org\/10.1152\/ajpheart.00720.2007 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"78321_CR43","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.metabol.2005.03.004","volume":"54","author":"B Glowinska","year":"2005","unstructured":"Glowinska, B., Urban, M., Peczynska, J. & Florys, B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism  54, 1020\u20131026. https:\/\/doi.org\/10.1016\/j.metabol.2005.03.004 (2005).","journal-title":"Metabolism"},{"key":"78321_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.diabres.2006.01.001","volume":"73","author":"D Seckin","year":"2006","unstructured":"Seckin, D., Ilhan, N., Ilhan, N. & Ertugrul, S. Glycaemic control, markers of endothelial cell activation and oxidative stress in children with type 1 diabetes mellitus. Diabetes Res. Clin. Pract. 73, 191\u2013197. https:\/\/doi.org\/10.1016\/j.diabres.2006.01.001 (2006).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"78321_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.110.237420","volume":"108","author":"PE Rautou","year":"2011","unstructured":"Rautou, P. E. et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration. Circ. Res. 108, 335\u2013343. https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.237420 (2011).","journal-title":"Circ. Res."},{"key":"78321_CR46","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41440-019-0211-0","volume":"42","author":"AS Bhuiyan","year":"2019","unstructured":"Bhuiyan, A. S. et al. Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice. Hypertens. Res. 42, 892\u2013902. https:\/\/doi.org\/10.1038\/s41440-019-0211-0 (2019).","journal-title":"Hypertens. Res."},{"key":"78321_CR47","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/s41440-020-0495-0","volume":"43","author":"K Arai","year":"2020","unstructured":"Arai, K., Morikawa, Y., Ubukata, N. & Sugimoto, K. Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker. Hypertens. Res. 43, 1204\u20131213. https:\/\/doi.org\/10.1038\/s41440-020-0495-0 (2020).","journal-title":"Hypertens. Res."},{"key":"78321_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.5551\/jat.63382","volume":"30","author":"U Munkhjargal","year":"2023","unstructured":"Munkhjargal, U. et al. A selective mineralocorticoid receptor blocker, esaxerenone, attenuates vascular dysfunction in diabetic C57BL\/6 mice. J. Atheroscler. Thromb. 30, 326\u2013334. https:\/\/doi.org\/10.5551\/jat.63382 (2023).","journal-title":"J. Atheroscler Thromb."},{"key":"78321_CR49","doi-asserted-by":"publisher","first-page":"8436","DOI":"10.1038\/s41598-017-08998-5","volume":"7","author":"K Taguchi","year":"2017","unstructured":"Taguchi, K. et al. Suppression of GRK2 expression reduces endothelial dysfunction by restoring glucose homeostasis. Sci. Rep. 7, 8436. https:\/\/doi.org\/10.1038\/s41598-017-08998-5 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78321-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T01:03:57Z","timestamp":1730423037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78321-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78321-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4331951\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"27 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a collaborative study supported by Daiichi Sankyo Co., Ltd. The Funder had no role in finalizing the study design, execution of experiments, decision to publish, or preparation of the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26266"}}